🦠 "Omicron BA.5 has been detected in at least 22 countries and territories 🌎 and is likely to become predominant in all the subregions during the next weeks" @DirOPSPAHO #COVID19 #omicron https://t.co/abxSoe1FUk

🌎 With Omicron variant sub-lineages BA.4 and BA.5 driving most new #COVID19 infections, and other diseases likely to emerge in the future, increased medical production is key to saving lives – @DirOPSPAHO.

ℹ️ Read more at: paho.org/en/news/13-7-2…

RT @campusvirtualsp: 📚Online course: Hypertension Control Drivers at Primary Health Care Centers ❤️

➡ Learn the main successful experience…

🌎 One example is the Revolving Fund – a pioneer financing and procurement mechanism established 40 years ago to ensure that vaccines approved for use and endorsed by WHO could quickly be made available to all countries in the region. @DirOPSPAHO #COVID19 paho.org/en/revolvingfu…

🌎 PAHO is rolling out several initiatives to increase the capacity of agencies in the Americas, including a new regional policy to strengthen national regulatory systems, which will guide countries as they promote innovation and respond to emergencies. @DirOPSPAHO #COVID19

🌎 As we have learned during the COVID-19 pandemic, manufacturing capacity alone is not sufficient to guarantee access.

But in our Region’s history, we have managed to reach millions more people when we work together.

@DirOPSPAHO #COVID19

🌎 Strengthening our Region’s medical production capacity has been on our to-do list since day one, but we cannot build all these systems and infrastructure immediately.

It is time to turn our rhetoric into action and our commitments into achievements.

@DirOPSPAHO #COVID19

🌎 We are coordinating across regional and international partners to shape a shared roadmap to improve health technologies production capacity in the Americas. @DirOPSPAHO #COVID19